search
Back to results

Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD (COMBIELEC)

Primary Purpose

Chronic Obstructive Pulmonary Disease Overlap Syndrome, Asthma

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Neuromuscular Electrical Stimulation
Sham Neuromuscular Electrical Stimulation
Sponsored by
University Hospital, Brest
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Chronic Obstructive Pulmonary Disease Overlap Syndrome focused on measuring Pulmonary Rehabilitation, Neuromuscular Electrical Stimulation, COPD, Muscular Strengthening

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient with COPD stages 2 to 4 (A to D) admitted to the Pulmonary Rehabilitation Department of the "Centre Hospitalier des Pays de Morlaix" or the "CHRU of Brest".
  • Patient aged 18 years or older.
  • Patient able to consent and having signed a consent form.

Exclusion Criteria:

  • Patient with a history of pneumonectomy, lobectomy dated less than 6 months old
  • Patient with an inability to complete a respiratory rehabilitation program in its entirety
  • Patient under guardianship or curatorship
  • Person equipped with electronic devices such as pacemakers and intracardiac defibrillators.
  • Skin lesions and infectious foci on the area where the electrodes.
  • Pregnant or breastfeeding women

Sites / Locations

  • CHU La Cavale BlancheRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Experimental group (EG)

Control group (CG)

Arm Description

Randomized intervention in the NMES (GE) group: Patients in the NMES group will receive, in addition to conventional rehabilitation, combined quadriceps femoris and triceps surae NMES. Detail of the NMES : Stimulation is performed in a semi-seated position, biphasic current, 8 channels in total (possibility of 16 electrodes). One device per lower limb of each patient is necessary: 4 electrodes are placed on the quadriceps and 4 electrodes on the triceps, on each lower limb. Stimulation frequency: 50hz. Pulse duration: 400 μs. Contraction time: 6 seconds. Rest time: 6 seconds. The intensity must generate a visible muscular contraction and must be well supported. by the patient. The voluntary contraction accompanies the electrical stimulation. Surface electrode 50 × 50 mm.

Patients in the control group (GC) will receive, in addition to the classical rehabilitation, the combined sham NMES of the quadriceps femoris and triceps surae. Detail of the NMES : It is carried out 5 times a week for 4 weeks, supervised by a physiotherapist. The device used will be the same as in the EG group. Stimulation is performed in a semi-seated position, biphasic current, 8 channels in total (16 electrodes can be used). One device per lower limb of each patient is required: 4 electrodes are placed on the quadriceps and 4 electrodes on the triceps, on each lower limb. Stimulation frequency: 5hz. Pulse duration: 100 μs. Contraction time: 6 seconds. Rest time: 6 seconds. The intensity must generate a visible muscle contraction and must be well supported by the patient. The voluntary contraction accompanies the electrical stimulation. Surface electrode 50 × 50 mm.

Outcomes

Primary Outcome Measures

Walking distance change
Assessment of the walking distance (in meters) covered during the 6-minute walking test before and after rehabilitation (between D0 and D28± 4 days). The main endpoint is the change (in meters) between Day 0 and Day 28.

Secondary Outcome Measures

Maximal isometric voluntary quadriceps strengh
Maximal isometric voluntary quadriceps strengh assessment (in newton) with handheld dynamometer
Maximal isometric voluntary endurance change
Maximal isometric voluntary endurance assessment with handheld dynamometer
Maximal isometric voluntary triceps surae strengh change
Maximal isometric voluntary triceps surae strengh assessment (in newton) with dynamometer type MICROFET 2 before and after rehabilitation.
Exercise capacity change with the 1 min sit to stand test
Exercise capacity assessment during the 1 min sit to stand test before and after rehabilitation.
Exercise capacity change with the 6 min step test
Exercise capacity assessment during the 6 min step test before and after rehabilitation.
Exercise capacity change with the incremental shuttle test
Exercise capacity assessment during the incremental shuttle test before and after rehabilitation.
Exercise capacity change with the endurance shuttle walk test
Exercise capacity assessment during the endurance shuttle walk test before and after rehabilitation. before and after rehabilitation.
Dyspnea change during the 6-minute walking test
Dyspnea assessment at the end of the 6-minute walking test, with the Borg scale, before and after rehabilitation
Dyspnea change during the 6-minute walking test
Dyspnea assessment at the end of the 6-minute walking test, with the Multidimensional dyspnea profile questionnaire, before and after rehabilitation
Isotime dyspnea change with the endurance shuttle walk test
Isotime dyspnea assessment during the endurance shuttle walk test, using Borg scale after rehabilitation.
Dyspnea change with the mMRC (modified Medical Research Council) scale
Assessment of dyspnea with the mMRC scale (min : 0 ; max : 4), before and after rehabilitation.
Dyspnea change with the LCADL (London Chest Activity of Daily Living) questionnaire
Assessment of dyspnea with the LCADL questionnaire (better score : 0; worse score: 5), before and after rehabilitation.
Dyspnea change with the Dyspnea-12 questionnaire
Assessment of dyspnea with the Dyspnea-12 questionnaire, before and after rehabilitation.
Quality of life change with the St George's Respiratory Questionnaire
Quality of life assessment with the St George's Respiratory Questionnaire, before and after rehabilitation.
Quality of life change with the CAT (COPD Assessment Test) Questionnaire
Quality of life assessment with COPD Assessment Test (better : 0; worse : 5), before and after rehabilitation.
Fear of fall change with the FES (Falls Efficacy Scale) questionnaire
Fear of fall (FES-I Questionnaire) assessment (better : 1; worse : 4), before and after rehabilitation.
Anxiety disorder change
Anxiety disorder assessment (HAD questionnaire) (better : 0; worse : 3) before and after rehabilitation.
Depressive disorder change
Depressive disorder assessment (HAD questionnaire) (better : 0; worse : 3) before and after rehabilitation.
Non fat mass index change
Assessment of the non fat mass index with impedancemetry , before and after rehabilitation.
Self esteem change
Self esteem assessment with PSI-6 (Physical Self Inventory) questionnaire (worse :0 ; better :10)

Full Information

First Posted
December 10, 2020
Last Updated
July 28, 2023
Sponsor
University Hospital, Brest
search

1. Study Identification

Unique Protocol Identification Number
NCT04684966
Brief Title
Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD
Acronym
COMBIELEC
Official Title
Interest of Adding Neuromuscular Electrical Stimulation for Quadriceps Femoris and Triceps Surae Muscles to Pulmonary Rehabilitation in COPD : Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 8, 2021 (Actual)
Primary Completion Date
November 6, 2023 (Anticipated)
Study Completion Date
November 6, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Brest

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Patients with COPD frequently have muscle disorders. Pathogenic mechanisms generate significant pathophysiological changes in the locomotor muscles structure, leading to decreased strength, decreased endurance and limited exercise capacity. Pulmonary rehabilitation is the first choice therapy and training overall lower limb endurance is a priority. Even if the effects of pulmonary rehabilitation are no longer to be demonstrated, it is still necessary to optimize the modalities of muscular strengthening. In fact, it is recommended to associate to this global endurance training a specific strengthening of the muscles of the lower limbs. Neuromuscular electrostimulation (NMES) is a muscular strengthening technique, but this method is not used in usual practice in pulmonary rehabilitation and often only the quadriceps are concerned. In a pulmonary rehabilitation program, including sessions of NMES of the quadriceps femoris and triceps surae could increase its effectiveness. Recent studies suggest that NMES can improve muscle function, exercise tolerance, dyspnea and quality of life in COPD patients. A pilot study compared the effects of the combined quadriceps femoris and triceps surae versus quadriceps alone. The final evaluation showed a greater improvement in exercise capacity in favour of the combined NMES group. Only two studies with small numbers of patients evaluated the effect of combined quadriceps femoris and triceps surae NMES in pulmonary rehabilitation, with encouraging results in terms of functional gain. Further larger studies seem necessary to evaluate the effects of combined quadriceps femoris and triceps surae NMES in pulmonary rehabilitation. The objective of the study is to show that combined quadriceps femoris and triceps surae NMES during a pulmonary rehabilitation program provides a more significant improvement in exercise capacity compared to a standard pulmonary rehabilitation program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease Overlap Syndrome, Asthma
Keywords
Pulmonary Rehabilitation, Neuromuscular Electrical Stimulation, COPD, Muscular Strengthening

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
266 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental group (EG)
Arm Type
Experimental
Arm Description
Randomized intervention in the NMES (GE) group: Patients in the NMES group will receive, in addition to conventional rehabilitation, combined quadriceps femoris and triceps surae NMES. Detail of the NMES : Stimulation is performed in a semi-seated position, biphasic current, 8 channels in total (possibility of 16 electrodes). One device per lower limb of each patient is necessary: 4 electrodes are placed on the quadriceps and 4 electrodes on the triceps, on each lower limb. Stimulation frequency: 50hz. Pulse duration: 400 μs. Contraction time: 6 seconds. Rest time: 6 seconds. The intensity must generate a visible muscular contraction and must be well supported. by the patient. The voluntary contraction accompanies the electrical stimulation. Surface electrode 50 × 50 mm.
Arm Title
Control group (CG)
Arm Type
Sham Comparator
Arm Description
Patients in the control group (GC) will receive, in addition to the classical rehabilitation, the combined sham NMES of the quadriceps femoris and triceps surae. Detail of the NMES : It is carried out 5 times a week for 4 weeks, supervised by a physiotherapist. The device used will be the same as in the EG group. Stimulation is performed in a semi-seated position, biphasic current, 8 channels in total (16 electrodes can be used). One device per lower limb of each patient is required: 4 electrodes are placed on the quadriceps and 4 electrodes on the triceps, on each lower limb. Stimulation frequency: 5hz. Pulse duration: 100 μs. Contraction time: 6 seconds. Rest time: 6 seconds. The intensity must generate a visible muscle contraction and must be well supported by the patient. The voluntary contraction accompanies the electrical stimulation. Surface electrode 50 × 50 mm.
Intervention Type
Device
Intervention Name(s)
Neuromuscular Electrical Stimulation
Intervention Description
Standart pulmonary rehabilitation with combined quadriceps and triceps surae ESNM using two identical electrotherapy devices allowing simultaneous stimulation of the quadriceps and triceps (EG group).
Intervention Type
Device
Intervention Name(s)
Sham Neuromuscular Electrical Stimulation
Intervention Description
Standart pulmonary rehabilitation with combined sham NMES of the quadriceps and triceps surae performed using two identical electrotherapy devices allowing simultaneous stimulation of the quadriceps and triceps (CG group)
Primary Outcome Measure Information:
Title
Walking distance change
Description
Assessment of the walking distance (in meters) covered during the 6-minute walking test before and after rehabilitation (between D0 and D28± 4 days). The main endpoint is the change (in meters) between Day 0 and Day 28.
Time Frame
Day 0 and Day 28
Secondary Outcome Measure Information:
Title
Maximal isometric voluntary quadriceps strengh
Description
Maximal isometric voluntary quadriceps strengh assessment (in newton) with handheld dynamometer
Time Frame
Day 0 and Day 28
Title
Maximal isometric voluntary endurance change
Description
Maximal isometric voluntary endurance assessment with handheld dynamometer
Time Frame
Day 0 and Day 28
Title
Maximal isometric voluntary triceps surae strengh change
Description
Maximal isometric voluntary triceps surae strengh assessment (in newton) with dynamometer type MICROFET 2 before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Exercise capacity change with the 1 min sit to stand test
Description
Exercise capacity assessment during the 1 min sit to stand test before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Exercise capacity change with the 6 min step test
Description
Exercise capacity assessment during the 6 min step test before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Exercise capacity change with the incremental shuttle test
Description
Exercise capacity assessment during the incremental shuttle test before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Exercise capacity change with the endurance shuttle walk test
Description
Exercise capacity assessment during the endurance shuttle walk test before and after rehabilitation. before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Dyspnea change during the 6-minute walking test
Description
Dyspnea assessment at the end of the 6-minute walking test, with the Borg scale, before and after rehabilitation
Time Frame
Day 0 and Day 28
Title
Dyspnea change during the 6-minute walking test
Description
Dyspnea assessment at the end of the 6-minute walking test, with the Multidimensional dyspnea profile questionnaire, before and after rehabilitation
Time Frame
Day 0 and Day 28
Title
Isotime dyspnea change with the endurance shuttle walk test
Description
Isotime dyspnea assessment during the endurance shuttle walk test, using Borg scale after rehabilitation.
Time Frame
Day 28
Title
Dyspnea change with the mMRC (modified Medical Research Council) scale
Description
Assessment of dyspnea with the mMRC scale (min : 0 ; max : 4), before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Dyspnea change with the LCADL (London Chest Activity of Daily Living) questionnaire
Description
Assessment of dyspnea with the LCADL questionnaire (better score : 0; worse score: 5), before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Dyspnea change with the Dyspnea-12 questionnaire
Description
Assessment of dyspnea with the Dyspnea-12 questionnaire, before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Quality of life change with the St George's Respiratory Questionnaire
Description
Quality of life assessment with the St George's Respiratory Questionnaire, before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Quality of life change with the CAT (COPD Assessment Test) Questionnaire
Description
Quality of life assessment with COPD Assessment Test (better : 0; worse : 5), before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Fear of fall change with the FES (Falls Efficacy Scale) questionnaire
Description
Fear of fall (FES-I Questionnaire) assessment (better : 1; worse : 4), before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Anxiety disorder change
Description
Anxiety disorder assessment (HAD questionnaire) (better : 0; worse : 3) before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Depressive disorder change
Description
Depressive disorder assessment (HAD questionnaire) (better : 0; worse : 3) before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Non fat mass index change
Description
Assessment of the non fat mass index with impedancemetry , before and after rehabilitation.
Time Frame
Day 0 and Day 28
Title
Self esteem change
Description
Self esteem assessment with PSI-6 (Physical Self Inventory) questionnaire (worse :0 ; better :10)
Time Frame
Day 0 and Day 28

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient with COPD stages 2 to 4 (A to D) admitted to the Pulmonary Rehabilitation Department of the "Centre Hospitalier des Pays de Morlaix" or the "CHRU of Brest". Patient aged 18 years or older. Patient able to consent and having signed a consent form. Exclusion Criteria: Patient with a history of pneumonectomy, lobectomy dated less than 6 months old Patient with an inability to complete a respiratory rehabilitation program in its entirety Patient under guardianship or curatorship Person equipped with electronic devices such as pacemakers and intracardiac defibrillators. Skin lesions and infectious foci on the area where the electrodes. Pregnant or breastfeeding women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Loïc Peran
Phone
02 98 62 61 60
Email
lperan@ch-morlaix.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Marc BEAUMONT
Phone
02 98 62 61 60
Email
mbeaumont@ch-morlaix.fr
Facility Information:
Facility Name
CHU La Cavale Blanche
City
Brest
ZIP/Postal Code
29200
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francis COUTURAUD, PHD
Phone
02 98 22 33 33
Email
francis.couturaud@chu-brest.fr
First Name & Middle Initial & Last Name & Degree
Christophe GUT-GOBERT, PHD
Phone
02 98 34 73 65
Email
chritophe.gut-gobert@chu-brest.fr

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD

We'll reach out to this number within 24 hrs